MedPath

Gecita-200

Brand Name: Gecita-200

Generic Name: Gemcitabine (as hydrochloride)

Active
Registration Number

DRP-12401

Dosage Form

Lyophilized Powder for I.V. Infusion

Issuance Date

August 2, 2022

Expiry Date

August 2, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength200 mg
PackagingUSP Type 1 clear moulded glass vial with rubber bromo butyl plug and blue flip off seal (Box of l’s)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic (Pyrimidine Analogue)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Gemcitabine (as hydrochloride)Active
Monograph: HPMA-gemcitabine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.